NewsDesk
The wire: crypto and markets news from other outlets, newest first.
AI summaryStories from the outlets we follow, summarised by AI and linked to the original. A story whose AI summary is not ready is held for an editor; older items may still show the outlet’s own summary, quoted and labelled. Bullish, Bearish and Neutral are an AI reading of a story’s tone, not investment advice.6 publishers845 storiesWhere AI is used
Saylor shares Strategy Bitcoin chart showing 849,327 BTC after sell-off
Michael Saylor posted a chart of Strategy's 849,327 BTC holdings, valued at $64.4bn, days after the company disclosed an 811 BTC purchase and a $208m preferred-stock buyback.
Open storyOn the Wire
Stories from our sources, newest first, each credited to the publisher and linked to the original.
Ngrave says phishing via hijacked alerts stole $2.56m from 70 wallets
The Belgian hardware-wallet maker says attackers used a third-party notification provider to send fake security warnings on 17 Oct, prompting customers to hand over recovery phrases.
UK crypto users file over 10,000 bank complaints, Stand With Crypto says
Stand With Crypto says 9,803 people filed more than 10,000 complaints about bank restrictions on crypto transfers between May and August 2026, with Lloyds and Barclays topping the list.
Qubic restarts chain and opens claims after $1.4m QU token hack
The layer-1 network resumed processing after validators backed a recovery plan, with 1,404 wallets affected by a predictable seed flaw able to claim until 1 May 2027.
CFTC sets 28 October agenda for first AI Frontier Forum
The US Commodity Futures Trading Commission's Innovation Task Force will host its first Frontier Forum on 28 October, with AI leaders discussing how machine intelligence may reshape derivatives market
Mastercard opens AI agent payments with Coinbase and Base support
Mastercard says it has completed end-to-end pilots of a platform that lets AI agents buy digital services using stablecoins, with Coinbase, Base and BVNK supplying the crypto infrastructure.
OpenAI buys Orchestra Bio to add drug programme agents to Rosalind
OpenAI has acquired Orchestra Bio, a San Francisco startup whose AI agents track drug development programmes, and will fold its team and platform into its Rosalind life sciences suite. Terms were not
